Background and Purpose-CADASIL is a hereditary arteriopathy causing recurrent strokes and cognitive decline. Because monozygotic twins have identical genetic background, differences in their environment and lifestyle could reveal factors that may influence CADASIL patients' clinical course, which is highly variable even within the same family. Methods-We describe differences in clinical and imaging findings in a pair of monozygotic CADASIL twins. Results-Twin B experienced his first-ever stroke 14 years earlier than twin A, and his symptoms, signs, and imaging findings were more severe. Distinguishing factors were twin B's smoking as well as twin A's physical activity and earlier statin treatment. Causative NOTCH3 mutation was a novel c.752GϾA -substitution (p.Cys251Tyr). 
C erebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a hereditary, adult-onset, systemic arteriopathy caused by a mutation in NOTCH3 gene, 1 which codes for NOTCH3 receptor molecule expressed in vascular smooth muscle cells (VSMCs). NOTCH3 mutations cause degeneration of VSMCs in small arteries with consequent fibrosis and stenosis of penetrating arteries in the cerebral white matter (WM). This results in recurrent subcortical lacunar infarcts and WM degeneration, detectable with MRI, which lead to progressive cognitive decline and finally to vascular dementia. Although 1 of the more than 170 different NOTCH3 mutations have been associated with earlier onset of CADASIL, 2,3 the reasons for the wide variation-even between patients with the same mutation-in the age of onset, severity of symptoms, rate of progression, and duration of the disease 4 are largely unknown.
Reports on discordance or phenotypic differences between monozygotic twins in Mendelian conditions are rare. 5-7 CADASIL has not been previously reported in monozygotic twins. We describe here the considerable variation in clinical symptoms and imaging findings in a pair of monozygotic CADASIL twins. Genetic analysis of the twins revealed a novel NOTCH3 mutation.
Case Reports Family History
Since the age of 70, the twins' mother had episodes of dysarthria and difficulties in concentration and developed memory problems. Diagnosis of vascular dementia was given on the basis of declined cognitive functions and WM hyperintensities as well as multiple small infarcts at the MRI. She died of cancer at the age of 72 years. Her CADASIL diagnosis was afterward verified based on the presence of characteristic histopathology in kidney arteries. The twins' father died at the age of 81. His postmortem neuropathological examination confirmed Alzheimer disease and also excluded CADASIL.
Pregnancy and delivery of the twin brothers were uneventful, but the nature of their placentation is unknown. The birth weights were 2340 g (twin A) and 2150 g (twin B), and height 46.5 cm for both.
Twin A
Twin A was normotensive, with normal blood glucose and homocysteine levels and modest alcohol consumption. He has been on simvastatin for hypercholesterolemia since the age of 43. Twin A has participated actively in sports since youth and has never smoked. Twin A was asymptomatic at the age of 47, although MRI showed mild changes in WM (Figure and  Table) . Low-dose aspirin treatment was prescribed. After the age of 49, he experienced episodes of losing consciousness, followed by nausea, abdominal pain, and dizziness. At the age of 50, positron emission tomography (PET) with 15 O-labeled water revealed significantly decreased (by 2 SD compared to healthy controls) cerebral blood flow (CBF) only in the pons ( Figure) . PET with 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) showed regional cerebral metabolic rate of glucose (rCMR gluc ) within normal variation. At the age of 53, he experienced his first stroke (dysarthria, dysphasia). Antidepressant was prescribed. At this age, MRI showed some progression ( Figure) and 11 lacunar infarcts were detected. At the age of 54 and 55 he experienced a stroke. At this time polycythemia (Hb 177 g/L, EVF 55%) was discovered. Venesection was conducted, and treatment with dipyridamol was initiated. His cognitive difficulties increased, he felt excessively exhausted wherefore he was no longer able to work full-time.
Twin B
Twin B was normotensive, his blood glucose and homocysteine levels were within reference values, and his alcohol consumption was light. Statin treatment was begun at the age of 48 after which his cholesterol values stayed within recommended values. He smoked daily from 14 to 38 years of age. He exercised lightly from young adulthood to the age of 54 when he had to stop because of physical exhaustion.
Twin B had the first stroke-like attack at the age of 39 with dysarthria as the main symptom. At the age of 47, several lacunar infarcts were visible in the MRI (Figure and Table) . After the second stroke-like attack, at the age of 48, slight dysarthria remained. Dipyridamol treatment was started. Shortly thereafter he had difficulties in fixating the gaze. CADASIL diagnosis was established on the basis of clinical features, MRI findings, and presence of granular osmiophilic material (GOM) in skin biopsy. Further, at the age of 49 and 54, twin B had 2 ischemic attacks and his cognitive and motor functions continued to deteriorate. PET examination at the age of 50 showed significantly decreased CBF (over 2 SD in all cortical areas except for the visual cortex). FDG PET scan disclosed similar but milder changes for the rCMR gluc . At the age of 53, MRI showed confluent WM hyperintensities and widened ventricles and perivascular spaces (Figure) . At this time he had 16 lacunar infarcts visible on the MRI. Since the age of 53, twin B has been permanently on disability pension.
Genetics
Monozygocity was confirmed with 10 genetic markers (99.9%). Sequencing of NOTCH3 exons 2 to 24 from both twins revealed a novel mutation, c.752GϾA (p.Cys251Tyr), in exon 5. The twins' apolipoprotein E (APOE) genotype was identified as 3/4.
Discussion
The NOTCH3 mutation discovered in the twins, c.752GϾA, p.Cys251Tyr, has not been previously reported. It replaces 1 cysteine residue in EGF repeat 6. Three other pathogenic mutations (p.Cys251ϾArg, 8 p.Cys251ϾSer, 9 p.Cys251ϾGly 10 ) have been described for this same codon.
Twin B experienced his first-ever ischemic attack 14 years earlier than twin A, and he experienced at least 4 attacks before twin A had his first definite attack. Furthermore, all twin B's symptoms, signs, and imaging findings (MRI and PET) were more severe than twin A's.
Genetic differences should not exist between monozygotic twins, but epigenetic alterations (DNA methylation and histone modifications) do increase during their lifetime as a result of nonshared environmental signals such as differences in nutrition, medications, physical and mental activity, use of alcohol, and smoking. 11 These and other environmental effects and lifestyle-related factors may have caused or contributed to the differences in our twins' phenotypes. The role of the environmental factors as a modifyer of CADASIL phenotype is also supported by our observation, that among the Finnish CADASIL patients with a common ancestral p.Arg133Cys mutation 12 the age at first-ever stroke has varied from 28 to 71 years. Even within a single Finnish family variation from 36 to 71 has been recorded. (M. Junna and M. Pöyhönen, unpublished data, 2008). However, variation in this cohort also includes the effects of genetic differences, whereas in the case of identical twins, we can focus exclusively on the environmental factors.
Smoking increases stroke risk in CADASIL patients, 13 and the effect of smoking is accentuated by APOE 4 allele (M. Junna, unpublished data, 2007), both applying to twin B. Furthermore, twin A's longer use of statin 14 could also have contributed to the later onset of symptoms and milder phenotype. In addition, twin A's more intensive physical activity may be another beneficial factor. 15 A further factor not commonly associated with CADASIL is increased blood viscosity, caused by polycythemia or dehydration, which appears to be harmful (Matti Viitanen, unpublished data, 2008). The former may be avoided by measuring patients' hemoglobin values regularly and the latter by advising the patients and their caregivers. and folic acid *Cognitive performance of the twins are given in z scores (zϭ0: mean reference value; zϭ1: 1 SD above mean; z ϭ Ϫ1: 1 SD under mean; zϭbetween Ϫ1 and 1: normal variation). Verbal functions: Similarities, 16 FASϭletter fluency, 17 Category fluency. 18 Visuospatial functions: Clock reading, Clock setting, 19 Rey-Osterrieth Complex Figure copying, 20 Block, Block Design, Block Design unpaced. 16 Executive functions: Digit Symbol, 16 Trail Making Test (TMT) A time, TMT B correct score and TMT B time. 21 Short-term memory: Digit Span; Digit Span forwards; Digit Span backwards. 16 Verbal episodic memory: Stockholm Geriatric Research Centre (SGRC) free recall and SGRC recognition 22 ; Rey Auditory Verbal Learning Test (RAVLT) total learning and RAVLT delayed recall. 21 Visual memory: Rey-Osterrieth (R-O) Complex Figure immediate reproduction. 21 Disability assessed according to modified Rankin Scale. 23, 24 #MRI hyperintensities are given as Scheltens scores 25 : 0 (no abnormalities), 1 (Ͻ3 mm and nՅ5), 2 (Ͻ3 mm and nϾ5), 3 (4 to 10 mm and nՅ5), 4 (4 to 10 mm and nϾ5), 5 (Ͼ10 mm and nՆ1), 6 (confluent).
Because CADASIL is a late-onset disabling disease with no curative treatment, identifying any beneficial lifestyle choices would be advantageous. Our experience suggests that at least smoking and high blood viscosity should be avoided.
